Clinical Trial Update: Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

View source ↗

Summary

A completed clinical trial update examining gene expression in patients with advanced or metastatic colorectal cancer treated with bevacizumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Colorectal Cancer | Status: COMPLETED